Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade C 42.17 -0.31% -0.13
PFE closed down 0.31 percent on Wednesday, March 20, 2019, on 86 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Up
See historical PFE trend table...

Date Alert Name Type % Chg
Mar 20 Fell Below 20 DMA Bearish 0.00%
Mar 20 50 DMA Support Bullish 0.00%
Mar 20 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 20 Cup with Handle Other 0.00%
Mar 20 Inside Day Range Contraction 0.00%
Mar 19 Crossed Above 20 DMA Bullish -0.31%
Mar 19 Crossed Above 50 DMA Bullish -0.31%
Mar 19 Cup with Handle Other -0.31%
Mar 19 Up 3 Days in a Row Strength -0.31%
Mar 18 Cup with Handle Other 0.86%

Older signals for PFE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Health Biopharmaceutical Pharmaceutical Industry Pain Disease Medication Pharmaceutical Products Inflammation Alzheimer's Disease Neuroscience Pain Management Cnx Nifty Dietary Supplements Pulmonary Arterial Hypertension Hemophilia Major Depressive Disorder Anti Infectives Pfizer Erectile Dysfunction Glaxosmithkline Livestock Producers Cardiovascular Endocrine Disorders Lupin Limited Non Pharmaceutical Products
Is PFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 46.47
52 Week Low 34.32
Average Volume 25,635,341
200-Day Moving Average 41.5969
50-Day Moving Average 42.1618
20-Day Moving Average 42.273
10-Day Moving Average 41.677
Average True Range 0.7271
ADX 19.67
+DI 19.0396
-DI 25.6452
Chandelier Exit (Long, 3 ATRs ) 41.6087
Chandelier Exit (Short, 3 ATRs ) 42.5213
Upper Bollinger Band 43.7576
Lower Bollinger Band 40.7884
Percent B (%b) 0.47
BandWidth 7.023869
MACD Line -0.1245
MACD Signal Line -0.1246
MACD Histogram 0.0001
Fundamentals Value
Market Cap 250.8 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 30.78
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 3.04%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.10
Resistance 3 (R3) 43.07 42.74 42.95
Resistance 2 (R2) 42.74 42.50 42.75 42.89
Resistance 1 (R1) 42.45 42.35 42.29 42.48 42.84
Pivot Point 42.12 42.12 42.03 42.13 42.12
Support 1 (S1) 41.83 41.88 41.67 41.86 41.50
Support 2 (S2) 41.50 41.73 41.51 41.45
Support 3 (S3) 41.21 41.50 41.40
Support 4 (S4) 41.24